adaptive radiotherapy in prostate cancer patients

Not Applicable

• Conditions: prostate cancer.; Dysplasia of prostate; N42.3

• Registration Number: IRCT20181006041257N1
• Lead Sponsor: Vice Chancellor for Research and Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 40

Inclusion Criteria

Patients with localised high-risk prostate carcinoma

Exclusion Criteria

previousprostatectomy
general contraindications for MRI (i.e. cardiac pacemaker,metal implants )

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Tumor volume. Timepoint: Before treatment and four months after radiotherapy. Method of measurement: diffusion weighted Images (DWI).;ADC. Timepoint: Before treatment and four months after radiotherapy. Method of measurement: diffusion weighted Images (DWI).;Prostate-specific antigen (PSA). Timepoint: Before treatment and four months after radiotherapy. Method of measurement: blood test.